Anxiety is aggravated with endorphin depletion in the midst of physical and mental stress.
Endorphin (endogenous morphine) “are involved in our natural reward circuits and are related to important activities like eating, drinking, physical fitness, and sexual intercourse. Endorphins also surge during pregnancy. They minimize discomfort and pain and maximize pleasure. This helps us to continue functioning despite injury or stress.
Since humans naturally seek to feel pleasure and avoid pain, we’re more likely to do an activity if it makes us feel good. From an evolutionary standpoint, this helps ensure survival.”
If you are sourcing your morphine from external sources, your brain ceases the production of its own endogenous morphine, that would lead to addiction of that external source, e.g. liquor, drugs, cigarette…
The best way to stimulate the brain to regenerate its own endorphins to mitigate anxiety is to use non-drug protocols like cranial electrostimulation. You can do this and more with NeuroSweep CES/tDCS technology.
In it’s User Manual, it says:
“All of the preset CES waveforms are premodulated for your convenience and are taken directly from a number of patents that are readily accessible through the Google Patent repository (Google Patents). For more information, just search for the given patent number, as indicated below:
ARB0 This waveform and frequency is said to be helpful in producing adrenaline.
ARB1 “requires administration over only 48-72 hours, and is most effective if initiated following the onset of symptoms of acute nicotine withdrawal” – US20140121740A1
ARB2 “The patient is stimulated with the device for between 20 minutes and two hours. Such stimulation results in an increase in the amplitude of P300 waves in the brain, which in turn is associated with a decrease in cravings for alcohol and drugs.” – US5342410A
ARB3 “can allow the user, especially those having dementia as in head injury, stroke and Alzheimer’s disease, to potentiate memory recovery by facilitating additional blood flow/oxygen to those areas of the brain involved in the neurons/plasticity process.” – US20060030897A1
ARB4 “has the potential to accelerate skill learning, with the key being to target a cortical region essential to the skill or to learning it, and to apply this treatment in conjunction with exercise of the skill.” – PMC4083569
ARB5 “treating… migraine and other primary headaches such as cluster headaches, including nasal or paranasal sinus symptoms that resemble an immune-mediated response (“sinus” headaches)… may also be used to treat rhinitis, sinusitis, or rhinosinusitis, irrespective of whether those disorders are co-morbid with a headache. They may also be used to treat other disorders that may be co-morbid with migraine or cluster headaches, such as anxiety disorders.” – US20110276107A1
ARB6 “A method of randomizing the stimulus at about 100 Hz for improved sleep and an alternate method of randomizing stimuli for the neurological reduction of perceived pain and a similar method for reducing pain output from a muscle and its associated tissues directly.” – US8265761B2
ARB7 “transcranial electrostimulation (TCES) or cranial electrostimulators (CES) have been used for a variety of noninvasive procedures, such as producing analgesic effects, reducing or controlling migraine headaches, and other applications of treatment and electro-anesthesia.” – US20030158589A1
ARB8 A method of eliciting analgesia in a human subject by Transcranial Electrical Stimulation (TCES) is provided. Electrodes are secured to the skin of the subject’s head and used to apply an electrical current to the electrodes. The current includes a direct current combined with rectangular current pulses (alternating current) delivered at a frequency of between 30 and 65 Hz. The frequency at which the pulses are delivered is periodically changed to a different value within the 30-65 Hz range. The total current supplied, a sum of the DC component and a Mean Absolute Deviation (MAD) of the current pulses, preferably has a value between 0.2 and 20 mA. The method is used during surgery and the post-operative procedure, and may also be used to treat a wide variety of neurological and other conditions.” – US6567702B1
ARB9 “This system is distinguished from previous forms of transcutaneous electrical nerve simulation (TENS) since MET uses far less current, but delivers the current in much longer pulses. Whereas the TENS devices must be constantly worn because they offer virtually no residual effect, the MET devices effects are long lasting and cumulative… The MET device is a precision technology which generates a modified square, bipolar waveform of 0.5, 1.5, or 100 pulses per second (Hz), at 50 to 600 microamperes (1 μA is one-millionth of an ampere), in a 50% duty cycle.” – WO2010047834A1
ARB10 is based on an actual mechanical vibratory machine that is found to be efficient in burning fat in conjunction with other fat burning routines and diets. There are also patents that are employing frequencies in the ultrasonic range, which may be used for the same purpose after a thorough research on the subject is made.
ARB11 Dubbed as Bob Beck’s Magic CES Frequencies 111Hz + 1000Hz, this is found to be good for increasing the production of beta-endorphin [painkiller] and cell regeneration. On another occasion, Beck mentioned that for bone regeneration, a 2.72kHz signal frequency at the site of fracture enhances healing.
ARB12 / ARB13 are two endorphin specific waveforms with frequencies that are found to be effective for alleviating pain, according to multiple literatures.
ARB14 is a waveform of frequencies that are found to stimulate the production of dopamine and serotonin. “In the brain, dopamine functions as a neurotransmitter—a chemical released by neurons (nerve cells) to send signals to other nerve cells. The brain includes several distinct dopamine pathways, one of which plays a major role in the motivational component of reward-motivated behavior.” – Wikipedia. Serotonin, on the other hand, has to do with social behavior, appetite and digestion, sleep, memory, and sexual desire.
ARB15 “create a suppression of natural electro-chemical activity in the brain associated with an alert mental state and awareness; and induce a lucid dream…” – US8267851B1
NOTE: The FDA approved 100Hz frequency is found to produce headaches in some patients. If that is your case, you can reduce the pain by shifting to the anti-migraine preset waveform ARB05 with the electrode pads placed in such a way that the current passes through the vagus nerve. You can avoid the experience by reducing the current, and by limiting your frequency sweep between 90-96Hz, or 104 to 111Hz only.” – NeuroSweep User Manual
According to the paper Cranial Electrotherapy Stimulation for Treatment of Anxiety, Depression, and Insomnia published by Daniel L. Kirsch, PhD and Francine Nichols, RN, PhD:
NEUROPHYSIOLOGIC EFFECTS AND RESEARCH STUDIES
“The brain functions electrochemically and can be readily modulated by electrical intervention. Research conducted at the Biomedical Engineering Program of the University of Texas at Austin indicated that from 1 mA of current, about 5 mA/cm2 of CES reaches the thalamic area at a radius of 13.30 mm and may facilitate the release of neurotransmitters, which in turn could cause physiologic effects such as relaxation.
CES is believed to affect the subcortical brain structures known to regulate emotions, such as the reticular activating system, thalamus, and hypothalamus, as well as the limbic system. CES may stimulate regions that regulate pain messages, neurotransmitter function, and hormone production via the hypothalamic-pituitary axis.
CES treatments induce significant changes in the electroencephalogram, increasing alpha (8–12 Hz) relative power and decreasing relative power in the delta (0–3.5 Hz) and beta (12.5–30 Hz) frequencies.
Increased alpha correlates with improved relaxation and increased mental alertness or clarity. Decreased delta waves indicate a reduction in fatigue. Beta-wave reductions between 20 and 30 Hz correlate with decreases in anxiety, ruminative thoughts, and obsessive/compulsive-like behaviors.
Low-resolution electromagnetic tomography and functional magnetic resonance imaging studies showed that CES reached all cortical and subcortical areas of the brain, producing changes similar to those induced by anxiolytic medications.
Many symptoms seen in psychiatric conditions, such as anxiety, insomnia, and attention deficit disorders, are thought to be exacerbated by excess cortical activation.
A recent functional magnetic resonance imaging study showed that CES causes cortical brain deactivation in the midline frontal and parietal regions of the brain after one 20-minute treatment.
CES treatments have been found to induce changes in neurohormones and neurotransmitters that have been implicated in psychiatric disorders: substantial increases in beta endorphins, adrenocorticotrophic hormone, and serotonin; moderate increases in melatonin and norepinephrine, modest or unquantified increases in cholinesterase, gamma-aminobutyric acid, and dehydroepiandrosterone, and moderate reductions in cortisol.
There is a wealth of data on CES from more than 40 years of research. In 3 randomized, double-blind, sham-controlled studies and 1 investigator-blind study with a control group that included 227 subjects, the active CES groups had significantly lower scores on anxiety outcome measures than the sham or control groups.
Effect sizes ranged from d = 0.60 (moderate) to d = 0.88 (high). Effect sizes from 2 open clinical trials (N = 208) investigating the efficacy of CES for anxiety were also robust at d = 0.75 (moderate) and d = 1.52 (very high) on the Four-dimensional Anxiety and Depression Scale and the Hamilton Anxiety Rating Scale (HARS), respectively.
CES was also shown to decrease depression and insomnia significantly.”
Logic of the Treatment
The absence of chemicals in CES treatment ensures that the brain will not continue halting its own endorphin production because it has no reason to do so.
If you use chemicals to eliminate anxiety, you’ll go into some painful withdrawal syndrome once you decide to quit from them. This is because the brain cannot regenerate the needed endorphins quickly.
So, before you jump into the chemical whirlpool, try cranial electrostimulation today. It’s a 5-decade technology that is now FDA-approved and is currently being used by the US Army as part of its protocol for PTSD.